Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Imperial College London
European Commission
Deutsche Forschungsgemeinschaft
Bundesministerium für Bildung und Forschung
Daiichi-Sankyo
Deutsche Herzstiftung
Deutsche Krebshilfe
University of Thessaly
Servier
Gemeinsame Bundesausschuss
Universitätsklinikum Heidelberg
Robert Koch Institut
Horizon 2020
Daiichi Sankyo Europe
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial
Patricia Martínez‐Sánchez, Mona Laible, Walter E. Haefeli, Sven Poli et al.
Citations
32 citations
Journal
The Lancet
Topics
Atrial Fibrillation Management and Outcomes
Field-Weighted Citation Impact (FWCI)
44.42
article
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial
Patricia Martínez‐Sánchez, Mona Laible, Walter E. Haefeli, Sven Poli, Deirdre A. Lane, Jan Purrucker, Viktoria S. Wurmbach, Morgane Lachaize, Kathrin I. Foerster, Valeria Caso, Peter Brønnum Nielsen, Christian Enzinger, Karim Hajjar, Carolin Schuhmann, Yolanda Silva, Peter U. Heuschmann, Lucio D’Anna, Marion Boulanger, Omid Halse, Viktoria Rücker, Roland C. Veltkamp, Simon Fandler‐Höfler, Peter A. Ringleb, Maria Giulia Mosconi, Joan Montaner, Cornelia Fießler, Sabine Ullmann, Guillaume Paré, Hatem A Wafa, Uwe Malzahn, Gabriele Putz Todd, Kirsten Haas, Charles D.A. Wolfe, Stefan Ropele, Bo Norrving, Virginia Cancelloni, George Ntaios, Elena Palà, Stéphanie Debette, Igor Sibon, Reyes de Torres Chacón, Yanzhong Wang, Melanie Haidegger, Rolf Wachter, Tim D’Aoust, Patrick Müller, Kirsten Harvey, Emily R. Harvey, Eleni Korompoki, Klemens Hügen, Gregory Y H Lip
article en
32 citations
Abstract
No abstract available for this paper.
Publication Tag
The LancetVol. 405(10482)
Institutions
Université de Bordeaux (FR), King's College London (GB), Universität Ulm (DE), Medical University of Graz (AT), Aristotle University of Thessaloniki (GR), Heidelberg University (DE), University of Würzburg (DE), University Hospital Heidelberg (DE), Hospital Universitario Virgen Macarena (ES), Bordeaux Population Health (FR), University Hospital Leipzig (DE), Universitätsklinikum Würzburg (DE), Skåne University Hospital (SE), Alfried Krupp Hospital (DE), Imperial College London (GB), Université de Caen Normandie (FR)
Funders
Amgen, Pfizer, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Imperial College London, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Daiichi-Sankyo, Deutsche Herzstiftung, Deutsche Krebshilfe, University of Thessaly, Servier, Gemeinsame Bundesausschuss, Universitätsklinikum Heidelberg, Robert Koch Institut, Horizon 2020, Daiichi Sankyo Europe